Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases

被引：61

作者：

Siva, Kavitha ^{[1
]}

Covello, Giuseppina ^{[1
]}

Denti, Michela A. ^{[1
,2
]}

机构：

[1] Univ Trento, Ctr Integrat Biol CIBIO, I-38123 Trento, Italy

[2] CNR, Inst Neurosci, Padua, Italy

来源：

NUCLEIC ACID THERAPEUTICS | 2014年 / 24卷 / 01期

关键词：

RESTORES DYSTROPHIN EXPRESSION; AMYLOID PRECURSOR PROTEIN; SPINAL MUSCULAR-ATROPHY; PEPTIDE NUCLEIC-ACID; PELIZAEUS-MERZBACHER-DISEASE; RECEPTOR-ALPHA CHAIN; BLOOD-BRAIN-BARRIER; BETA-TRACE PROTEIN; LONG-TERM RESCUE; MDX MICE;

D O I：

10.1089/nat.2013.0461

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Alternative splicing is an important regulator of the transcriptome. However, mutations may cause alteration of splicing patterns, which in turn leads to disease. During the past 10 years, exon skipping has been looked upon as a powerful tool for correction of missplicing in disease and progress has been made towards clinical trials. In this review, we discuss the use of antisense oligonucleotides to correct splicing defects through exon skipping, with a special focus on diseases affecting the nervous system, and the latest stage achieved in its progress.

引用

页码：69 / 86

页数：18

共 133 条

[61] Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles [J].

Kanazawa, T. ;

Akiyama, F. ;

Kakizaki, S. ;

Takashima, Y. ;

Seta, Y. .

BIOMATERIALS, 2013, 34 (36) :9220-9226

[62] Up-regulation of luciferase gene expression with antisense oligonucleotides: Implications and applications in functional assay developments [J].

Kang, SH ;

Cho, MJ ;

Kole, R .

BIOCHEMISTRY, 1998, 37 (18) :6235-6239

[63] Deletion of individual exons and induction of soluble murine interleukin-5 receptor-α chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing [J].

Karras, JG ;

McKay, RA ;

Dean, NM ;

Monia, BP .

MOLECULAR PHARMACOLOGY, 2000, 58 (02) :380-387

[64] Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-α chain [J].

Karras, JG ;

Maier, MA ;

Lu, T ;

Watt, A ;

Manoharan, M .

BIOCHEMISTRY, 2001, 40 (26) :7853-7859

[65]

Kheder Ammar, 2013, Pract Neurol, V13, P382, DOI 10.1136/practneurol-2013-000525

[66]

Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X

[67] Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis [J].

Kordasiewicz, Holly B. ;

Stanek, Lisa M. ;

Wancewicz, Edward V. ;

Mazur, Curt ;

McAlonis, Melissa M. ;

Pytel, Kimberly A. ;

Artates, Jonathan W. ;

Weiss, Andreas ;

Cheng, Seng H. ;

Shihabuddin, Lamya S. ;

Hung, Gene ;

Bennett, C. Frank ;

Cleveland, Don W. .

NEURON, 2012, 74 (06) :1031-1044

[68] Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice [J].

Kumar, VB ;

Farr, SA ;

Flood, JF ;

Kamlesh, V ;

Franko, M ;

Banks, WA ;

Morley, JE .

PEPTIDES, 2000, 21 (12) :1769-1775

[69] Antisense properties of peptide nucleic acid [J].

Larsen, HJ ;

Bentin, T ;

Nielsen, PE .

BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1489 (01) :159-166

[70]

LASSUTHOVa P., 2013, J CHILD NEUROL

← 2 3 4 5 6 7 8 9 10 11 →